Category: Boston ScientificSyndicate content

J&J deals Cordis for nearly $2B | The week in medtech M&A

March 4, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: J&J deals Cordis to Cardinal Health for nearly $2B; Cyberonics to buy Italy's Sorin for $1.4B; Boston Scientific to buy Endo's urology portfolio for $1.65B; Nikon pushes into medtech with $400 mln Optos acquisition; Allergan CEO in line for $100M payout from Actavis deal

J&J deals Cordis to Cardinal Health for nearly $2B

March 2, 2015 by Brad Perriello

FDA clears BSX's new SpyGlass | Regulatory news for the week of March 2, 2015

March 3, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: FDA clears new version of Boston Scientific's SpyGlass; Joint FDA panel recommends OK for Avedro's eye treatment; Staar Surgical posts Q4, 2014 losses; FDA removes unregistered medical device establishments from database; FDA panel to review brain aneurysm devices

FDA clears new version of Boston Scientific's SpyGlass

February 26, 2015 by Brad Perriello

Confirmed: Boston Scientific to buy Endo's urology portfolio for $1.65B

March 2, 2015 by Brad Perriello

Boston Scientific confirms speculation with a $1.65 billion bid for Endo International's urology business, not including its star-crossed American Medical Systems pelvic mesh business.

Boston Scientific to buy Endo's urology portfolio for $1.65B

FDA clears new version of Boston Scientific's SpyGlass

February 26, 2015 by Brad Perriello

Boston Scientific says the FDA cleared the SpyGlass DS version of its cholangioscopy and pancreatoscopy device.

FDA clears new version of Boston Scientific's SpyGlass

Boston Scientific (NYSE:BSX) said the FDA granted 510(k) clearance for the latest iteration in its line of cholangioscopy and pancreatoscopy devices, the SpyGlass DS.

Report: Is Boston Scientific closing in on deal for Endo's AMS medical device unit?

February 24, 2015 by Brian Johnson

Endo Health Solutions may have found a buyer for its American Medical Systems subsidiary in Boston Scientific, according to a Reuters report.

Endo International, PLC (NSDQ:ENDP) may have found a buyer for its American Medical Systems subsidiary after months of speculation that the Irish pharma company had put its medical device business on the block.

Report: C.R. Bard to settle W. Va. pelvic-mesh case

February 24, 2015 by Val Kennedy

C. R. Bard is reportedly close to settling a suit filed in a West Virginia federal court by a woman who claimed she was injured by the company's pelvic-mesh device, Avaulta Plus.

Bard loses bid to delay pelvic mesh cases over judge's comments

C.R. Bard (NYSE:BCR) is reportedly close to settling a suit filed in West Virginia federal court by a woman who claimed she was injured by the company's pelvic-mesh device, Avaulta Plus.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.